Cell Marque Portfolio

GCDFP-15 (23A3)

Mouse Monoclonal


GCDFP-15 is a 15 kD glycoprotein which is localized in the apocrine metaplastic epithelium lining breast cysts and in apocrine glands in the axilla, vulva, eyelid, ear canal, and in salivary glands.1 GCDFP-15 positivity is seen in breast carcinomas.2,4-6 On the other hand, colorectal carcinomas, lung carcinoma, mesothelimas rarely stain with this antibody.3 Because of its specificity for breast carcinoma, this antibody is often helpful in distinguishing metastasis of unknown primary.4,6-10

Specialties: Breast/Gynecological Pathology

Specifications


  • Reactivity: paraffin
  • Visualization: cytoplasmic
  • Control: breast, breast carcinoma
  • Isotype: IgG2a
  • Dilution Range: 1:50-1:200*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/Perm Red
  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Ventana ultraView
    UV/CC1M/16min @ 37°C

References


  1. Mazoujian G, et al. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol. 1988; 10:28-35.
  2. Ansai S, et al. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol. 1995; 17:249-55.
  3. Mazoujian G, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983; 110:105-12.
  4. Wich MR, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989; 20:281-7.
  5. Cohen C, et al. Mammary Paget's disease and associated carcinoma. An immunohistochemical study. Arch Pathol Lab Med. 1993; 117:291-4.
  6. Liegl B, et al. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases. Histopathology. 2007; 50:439-47.
  7. Raju U, et al. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study. Mod Pathol. 1993; 6:516-20.
  8. Bhargava R, et al. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007; 127:103-13.
  9. Tornos C, et al. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol. 2005; 29:1482-9.
  10. Takeda Y, et al. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med. 2008; 132:239-43.

Last updated: 2017-05-24 08:46:09

GCDFP-15
Breast invasive ductal carcinoma displays strong positivity with GCDFP-15 antibody.

Mouse over to zoom, use scroll wheel to zoom in/out

Tap image once to activate zoom lens


Specifications


  • Reactivity: paraffin
  • Visualization: cytoplasmic
  • Control: breast, breast carcinoma
  • Isotype: IgG2a
  • Dilution Range: 1:50-1:200*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/Perm Red
  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Ventana ultraView
    UV/CC1M/16min @ 37°C

References


  1. Mazoujian G, et al. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol. 1988; 10:28-35.
  2. Ansai S, et al. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol. 1995; 17:249-55.
  3. Mazoujian G, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983; 110:105-12.
  4. Wich MR, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989; 20:281-7.
  5. Cohen C, et al. Mammary Paget's disease and associated carcinoma. An immunohistochemical study. Arch Pathol Lab Med. 1993; 117:291-4.
  6. Liegl B, et al. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases. Histopathology. 2007; 50:439-47.
  7. Raju U, et al. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study. Mod Pathol. 1993; 6:516-20.
  8. Bhargava R, et al. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007; 127:103-13.
  9. Tornos C, et al. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol. 2005; 29:1482-9.
  10. Takeda Y, et al. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med. 2008; 132:239-43.

Package Inserts

Select revision:



Ordering Information

For in vitro diagnostic (IVD) use in USA

0.1 mL concentrate 257M-14
0.5 mL concentrate 257M-15
1 mL concentrate 257M-16
1 mL predilute 257M-17
7 mL predilute 257M-18
25 mL predilute 257M-10

For in vitro diagnostic (IVD) use in Canada

0.1 mL concentrate 257M-14
0.5 mL concentrate 257M-15
1 mL concentrate 257M-16
1 mL predilute 257M-17
7 mL predilute 257M-18
25 mL predilute 257M-10

For in vitro diagnostic (IVD) use in the EU

0.1 mL concentrate 257M-14
0.5 mL concentrate 257M-15
1 mL concentrate 257M-16
1 mL predilute 257M-17
7 mL predilute 257M-18
25 mL predilute 257M-10

For research use only (RUO) in Japan

0.1 mL concentrate 257M-14-RUO
0.5 mL concentrate 257M-15-RUO
1 mL concentrate 257M-16-RUO
1 mL predilute 257M-17-RUO
7 mL predilute 257M-18-RUO
25 mL predilute 257M-10-RUO

Specifications


  • Reactivity: paraffin
  • Visualization: cytoplasmic
  • Control: breast, breast carcinoma
  • Isotype: IgG2a
  • Dilution Range: 1:50-1:200*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/Perm Red
  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Ventana ultraView
    UV/CC1M/16min @ 37°C

Download Package Insert

Select revision:


Keycode Specific Package Insert

Keycode:
Select prefix.
Please verify your keycode and try again. If problems presist contact Customer Service
Enter keycode.
Please verify your keycode and try again. If problems presist contact Customer Service

Some products may have special labeling requirements in the United States.

Are you located in the U.S.?


*Note: IFUs with the prefix RUO or ASR are only available for download in English.



Click here to learn about keycodes

Download SDS

References


  1. Mazoujian G, et al. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol. 1988; 10:28-35.
  2. Ansai S, et al. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol. 1995; 17:249-55.
  3. Mazoujian G, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983; 110:105-12.
  4. Wich MR, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989; 20:281-7.
  5. Cohen C, et al. Mammary Paget's disease and associated carcinoma. An immunohistochemical study. Arch Pathol Lab Med. 1993; 117:291-4.
  6. Liegl B, et al. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases. Histopathology. 2007; 50:439-47.
  7. Raju U, et al. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study. Mod Pathol. 1993; 6:516-20.
  8. Bhargava R, et al. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007; 127:103-13.
  9. Tornos C, et al. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol. 2005; 29:1482-9.
  10. Takeda Y, et al. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med. 2008; 132:239-43.
Request More Information